Literature DB >> 24658836

A shorter telomere is the key factor in preventing cultured human mesenchymal stem cells from senescence escape.

Liu He, Yong Zheng, Yu Wan, Jian Song.   

Abstract

Mesenchymal stem cells (MSCs) from various animals undergo spontaneous transformation in vitro,establishing some malignant characteristics. However,this phenomenon seems seldom appearing in human (h)MSCs. To address the question whether the hMSCs really do not undergo the spontaneous transformation and why,the present study compared MSCs from two species under the same conditions, the commercialized primary hMSCs whose in vitro life span is very uniform, and the rat (r)MSCs whose spontaneous transformation in vitro is well defined.It was demonstrated that in rMSCs, there were small numbers of re-proliferating cells appearing after a substantial senescent period. These “senescence-escaped”rMSCs were highly proliferative and did not show any sign of growth arrest during the following subcultures upto observed passage 32. Whereas after entering senescence, hMSCs no longer re-proliferated and finally died from apoptosis. Compared with rMSCs, the hMSCs possessed a much shorter telomere, and lacked both telomerase reverse transcriptase expression and telomerase activity. When proliferating from pre-senescent to senescent stages,the hMSCs had a greater loss of relative telomere length(51 % in hMSC vs. 15 % in rMSC), but both cells displayed a similar average telomere shortening per population doubling (0.50 ± 0.06 kb in rMSC vs. 0.49 ± 0.06 kbin hMSC; p > 0.05), indicating that the greater relative shortening of the hMSC telomeres was due to their original shorter length, rather than lack of telomere maintenance mechanisms. In conclusion, the hMSCs do not spontaneously initiate transformation, because they cannot escape senescence. This is particularly due to their much shorter telomere.

Entities:  

Mesh:

Year:  2014        PMID: 24658836     DOI: 10.1007/s00418-014-1210-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  50 in total

1.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Authors:  Mariam A Stoff-Khalili; Angel A Rivera; J Michael Mathis; N Sanjib Banerjee; Amanda S Moon; A Hess; Rodney P Rocconi; T Michael Numnum; M Everts; Louise T Chow; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; Hans Georg Bender; Peter Dall; Alexander Stoff; Larissa Pereboeva; David T Curiel
Journal:  Breast Cancer Res Treat       Date:  2007-01-13       Impact factor: 4.872

3.  Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

Authors:  Jin-Ok Jeong; Ji Woong Han; Jin-Man Kim; Hyun-Jai Cho; Changwon Park; Namho Lee; Dong-Wook Kim; Young-Sup Yoon
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

4.  Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.

Authors:  Y Wang; D L Huso; J Harrington; J Kellner; D K Jeong; J Turney; I K McNiece
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

5.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

6.  Malignant transformation of rat bone marrow-derived mesenchymal stem cells treated with 4-nitroquinoline 1-oxide.

Authors:  Shujuan Zhang; Zhijuan Han; Qingfei Kong; Jinghua Wang; Bo Sun; Guangyou Wang; Lili Mu; Dandan Wang; Yumei Liu; Hulun Li
Journal:  Chem Biol Interact       Date:  2010-06-23       Impact factor: 5.192

7.  Cellular and transcriptomic analysis of human mesenchymal stem cell response to plasma-activated hydroxyapatite coating.

Authors:  Fei Tan; Feidhlim O'Neill; Mariam Naciri; Denis Dowling; Mohamed Al-Rubeai
Journal:  Acta Biomater       Date:  2011-12-16       Impact factor: 8.947

8.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells.

Authors:  Yi Fu Zhou; Marta Bosch-Marce; Hiroaki Okuyama; Balaji Krishnamachary; Hideo Kimura; Li Zhang; David L Huso; Gregg L Semenza
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

9.  Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.

Authors:  Alexander B Mohseny; Karoly Szuhai; Salvatore Romeo; Emilie P Buddingh; Inge Briaire-de Bruijn; Daniëlle de Jong; Melissa van Pel; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

10.  Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture.

Authors:  Rita A Busuttil; Miguel Rubio; Martijn E T Dollé; Judith Campisi; Jan Vijg
Journal:  Aging Cell       Date:  2003-12       Impact factor: 9.304

View more
  8 in total

Review 1.  Targeting Stem Cells in Chronic Inflammatory Diseases.

Authors:  Mari van de Vyver; Carine Smith; Yigael S L Powrie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The Histochemistry and Cell Biology pandect: the year 2014 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2015-03-06       Impact factor: 4.304

3.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

4.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

Review 5.  Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?

Authors:  Alessandro Castorina; Marta Anna Szychlinska; Rubina Marzagalli; Giuseppe Musumeci
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

6.  Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells.

Authors:  Yongzhao Zhu; Xumei Song; Fei Han; Yukui Li; Jun Wei; Xiaoming Liu
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

Review 7.  Current perspectives in mesenchymal stem cell therapies for osteoarthritis.

Authors:  Baldur Kristjánsson; Sittisak Honsawek
Journal:  Stem Cells Int       Date:  2014-12-08       Impact factor: 5.443

Review 8.  The Mechanism of Stem Cell Aging.

Authors:  Liangyu Mi; Junping Hu; Na Li; Jinfang Gao; Rongxiu Huo; Xinyue Peng; Na Zhang; Ying Liu; Hanxi Zhao; Ruiling Liu; Liyun Zhang; Ke Xu
Journal:  Stem Cell Rev Rep       Date:  2022-01-09       Impact factor: 6.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.